LONDON (Reuters) - The prospect of generic copies of GlaxoSmithKline's best-selling lung drug Advair finally making it to market in the United States hit confidence in the drugmaker on Tuesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results